Taylor Frigon Capital Management LLC Compugen LTD Transaction History

Taylor Frigon Capital Management LLC

$199 Million
Q3 2024

A detailed history of Taylor Frigon Capital Management LLC transactions in Compugen LTD stock. As of the latest transaction made, Taylor Frigon Capital Management LLC holds 1,201,523 shares of CGEN stock, worth $1.74 Million. This represents 1.09% of its overall portfolio holdings.

Number of Shares

1,201,523

Previous 1,314,433 8.59%

Holding current value

$1.74 Million

Previous $2.21 Million 1.54%

% of portfolio

1.09%

Previous 1.06%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$1.56 - $2.1 $176,139 - $237,111	-112,910 Reduced 8.59%	1,201,523 $2.17 Million
Q2 2024 Jul 29, 2024	SELL	$1.68 - $2.52 $12,260 - $18,390	-7,298 Reduced 0.55%	1,314,433 $2.21 Million
Q1 2024 Apr 19, 2024	SELL	$1.75 - $2.95 $1 Million - $1.69 Million	-572,981 Reduced 30.24%	1,321,731 $3.41 Million
Q4 2023 Jan 29, 2024	SELL	$0.53 - $2.0 $17,821 - $67,252	-33,626 Reduced 1.74%	1,894,712 $3.75 Million
Q3 2023 Oct 25, 2023	SELL	$0.88 - $1.31 $57,084 - $84,978	-64,869 Reduced 3.25%	1,928,338 $1.79 Million
Q2 2023 Jul 28, 2023	SELL	$0.57 - $1.38 $6,490 - $15,714	-11,387 Reduced 0.57%	1,993,207 $2.27 Million
Q1 2023 Apr 25, 2023	BUY	$0.68 - $1.11 $395,188 - $645,086	581,159 Added 40.83%	2,004,594 $1.4 Million
Q4 2022 Feb 03, 2023	SELL	$0.58 - $1.2 $71,633 - $148,207	-123,506 Reduced 7.98%	1,423,435 $1.02 Million
Q3 2022 Nov 04, 2022	BUY	$0.66 - $2.32 $581,014 - $2.04 Million	880,325 Added 132.06%	1,546,941 $1.02 Million
Q2 2022 Aug 04, 2022	SELL	$1.57 - $3.33 $8,539 - $18,111	-5,439 Reduced 0.81%	666,616 $1.23 Million
Q1 2022 Apr 25, 2022	BUY	$2.76 - $4.64 $35,242 - $59,248	12,769 Added 1.94%	672,055 $2.16 Million
Q4 2021 Jan 21, 2022	BUY	$4.09 - $7.16 $3,255 - $5,699	796 Added 0.12%	659,286 $2.84 Million
Q3 2021 Oct 27, 2021	BUY	$5.8 - $8.02 $34,788 - $48,103	5,998 Added 0.92%	658,490 $3.93 Million
Q2 2021 Jul 26, 2021	BUY	$6.87 - $9.16 $464,137 - $618,849	67,560 Added 11.55%	652,492 $5.4 Million
Q1 2021 Apr 23, 2021	BUY	$7.67 - $13.77 $108,446 - $194,694	14,139 Added 2.48%	584,932 $5.03 Million
Q4 2020 Jan 22, 2021	BUY	$12.07 - $17.95 $659,613 - $980,949	54,649 Added 10.59%	570,793 $6.91 Million
Q3 2020 Oct 20, 2020	BUY	$14.16 - $19.45 $120,430 - $165,422	8,505 Added 1.68%	516,144 $8.39 Million
Q2 2020 Jul 22, 2020	SELL	$6.97 - $17.12 $869,598 - $2.14 Million	-124,763 Reduced 19.73%	507,639 $7.63 Million
Q1 2020 May 06, 2020	BUY	$5.79 - $11.83 $609,646 - $1.25 Million	105,293 Added 19.98%	632,402 $4.59 Million
Q1 2020 Apr 24, 2020	SELL	$5.79 - $11.83 $1.13 Million - $2.3 Million	-194,396 Reduced 26.94%	527,109 $3.83 Million
Q4 2019 Jan 24, 2020	SELL	$3.9 - $6.16 $108,373 - $171,174	-27,788 Reduced 3.71%	721,505 $4.3 Million
Q3 2019 Nov 01, 2019	SELL	$3.01 - $4.49 $33,504 - $49,978	-11,131 Reduced 1.46%	749,293 $3.17 Million
Q2 2019 Jul 17, 2019	BUY	$2.8 - $4.14 $219,178 - $324,070	78,278 Added 11.48%	760,424 $2.92 Million
Q1 2019 Apr 25, 2019	SELL	$2.35 - $4.19 $19,072 - $34,006	-8,116 Reduced 1.18%	682,146 $2.82 Million
Q4 2018 Feb 07, 2019	BUY	$2.17 - $3.8 $219,630 - $384,605	101,212 Added 17.18%	690,262 $1.5 Million
Q3 2018 Oct 15, 2018	SELL	$3.0 - $4.05 $231,756 - $312,870	-77,252 Reduced 11.59%	589,050 $2.27 Million
Q2 2018 Aug 01, 2018	BUY	$3.15 - $4.7 $410,183 - $612,019	130,217 Added 24.29%	666,302 $2.2 Million
Q1 2018 Apr 23, 2018	BUY	$2.5 - $4.45 $587,415 - $1.05 Million	234,966 Added 78.03%	536,085 $2.39 Million
Q4 2017 Feb 15, 2018	BUY	$2.35 - $4.0 $42,770 - $72,800	18,200 Added 6.43%	301,119 $753,000
Q4 2017 Jan 25, 2018	BUY	$2.35 - $4.0 $664,859 - $1.13 Million	282,919	282,919 $707,000

Others Institutions Holding CGEN

# of Institutions

Shares Held

13.1M

Call Options Held

79.2K

Put Options Held

12.7K

View Full List

About COMPUGEN LTD

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $126M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

More about CGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Taylor Frigon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Taylor Frigon Capital Management LLC with notifications on news.

Account

Taylor Frigon Capital Management LLC Compugen LTD Transaction History